FDA Issues Four Wound Care Precautions
Hospitals and long-term care facilities should be on the lookout for serious complications and risk of death resulting from use of negative pressure wound therapy (NPWT) systems that can cause fatal bleeding and infections, said the U.S. Food and Drug Administration in a Medwatch Safety Alert issued this week.
"FDA has received reports of six deaths and 77 injuries associated with NPWT systems over the past two years," the FDA said. "Although rare, complications can occur wherever these systems are used... Bleeding was the most serious complication, reported in all of the six deaths and in 17 of the injury reports."
Extensive bleeding occurred in patients with vascular grafts, in sternal and groin wounds, in patients receiving anti-coagulant therapy, and during removal of dressings.
The FDA said 32 reports involved foam dressing retention in the wound, and the majority required surgery to remove the retained pieces.
NPWT systems use a vacuum component that creates a negative pressure within a sealed wound. The system is used for wounds, burns, ulcers, flaps, and grafts. They apply negative pressure in order to remove fluids, including irrigation fluids and infectious material.
- New G-Codes to Pay Doctors for Broad Array of Non-Face-to-Face Care
- CMS Sets 2014 Pay Rates for Hospital Outpatient and Physician Services
- States Rejecting Medicaid Expansion Forgo Billions in Federal Funds
- Douglas Hawthorne—A Chance to Do Something Big
- Telehealth Improves Patient Care in ICUs
- Why You Should Involve Patients in Nursing Handoffs
- Hospital M&A Volume Up, Value Down in 3Q
- Not-for-Profit Hospitals Find Opportunity Amid Uncertainty
- The 5 Biggest Healthcare Finance Trouble Spots
- 50 Years of Fighting Pressure Ulcers Called Into Question